Identification of MiR-93-5p Targeted Pathogenic Markers in Acute Myeloid Leukemia through Integrative Bioinformatics Analysis and Clinical Validation

Table 1

Clinical information of the patient with AML from TCGA.

Patient characteristic	Total
Age	54.17 ± 17.07
Gender
Male	83
Female	68
Leukocyte	35.02 ± 41.34
Monocyte	11.72 ± 15.13
Hemoglobin	9.47 ± 1.62
Platelet	64.38 ± 53.13
FAB classification systems
Mo	15
M1	35
M2	38
M3	15
M4	29
M5	15
M6	2
M7	1
Not classified	1
Cytogenetics risk
Unclassified	2
Favorable	31
Intermediate/normal	82
Poor	36

Note: FAB classification systems, French-American-British classification systems.